TRACER to support Akston Biosciences’ Phase 1 clinical study of AKS-452, an innovative anti-COVID-19 vaccine
September 01, 2020 12:41 ET | Akston Biosciences
BEVERLY, Mass., USA & GRONINGEN, the Netherlands, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Today, TRACER Europe B.V. (“TRACER”), a Clinical Research Organization (CRO) specializing in fast-track...
Knoema Organizes Coalition of Alternative Data Providers to Support COVID-19 Knowledge Sharing and Policy Making
April 16, 2020 08:42 ET | Knoema
New York, April 16, 2020 (GLOBE NEWSWIRE) -- Knoema, the provider of an end-to-end data and knowledge management platform and one of the largest global repositories of public data, is partnering...